AIM
MXCT icon

Aigen Investment Management’s MaxCyte MXCT Stock Holding History

Aigen Investment Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,819
Closed -$21.4K – 699
2025
Q4 		$21.4K Buy
+13,819
New +$22.1K 0.01% 548
2023
Q4 		– Sell
-14,169
Closed -$44.2K – 973
2023
Q3 		$44.2K Buy
+14,169
New +$57K 0.01% 775
2022
Q1 		– Sell
-11,788
Closed -$120K – 891
2021
Q4 		$120K Buy
+11,788
New +$127K 0.01% 980

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

Aigen Investment Management's MXCT Position: Q1 2026 in Review

Aigen Investment Management sold out of MaxCyte (MXCT) in Q1 2026, closing a stake of 13,819 shares — an estimated $21.4K sold.

Aigen Investment Management first reported a position in MXCT in Q4 2021 and held it in 3 quarters. The position peaked at $120K in Q4 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Aigen Investment Management reported no remaining MaxCyte position as of Q1 2026 after selling out during the quarter.
  • Aigen Investment Management sold 13,819 MaxCyte shares in Q1 2026, an estimated $21.4K.
  • Aigen Investment Management first reported a position in MaxCyte in Q4 2021 and held it in 3 quarters.
  • Aigen Investment Management's MaxCyte position peaked at $120K in Q4 2021.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.